Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Gazprom updated the record of daily gas supplies via Siberia Power

1/3/24 GAZP

EU imposes sanctions on Alrosa and its CEO

1/3/24 ALRS

TCS Group announces delisting of receipts from LSE

1/3/24 T

LSR bought back its shares from Arsagera funds

12/29/23 LSRG

LSR bought back its shares from Arsagera funds

12/29/23 ARSA

Fix Price co-founder Artem Khachatryan has withdrawn from the retailer's capital

12/29/23 FIXP

Anna Meleshina became General Director of Magnit

12/29/23 MGNT

Unmanned Kamazy will deliver goods to Wildberries

12/29/23 KMAZ

Transneft share split to take place a week later

12/29/23 TRNFP

Shareholders of Magnit approved dividends

12/29/23 MGNT